How should opioid‑induced pruritus be managed in an adult patient receiving morphine, oxycodone, or hydromorphone for pain while preserving analgesia?

Management of Opioid-Induced Pruritus

Start with antihistamines (diphenhydramine 25-50 mg IV/PO every 6 hours or promethazine 12.5-25 mg PO every 6 hours) as first-line therapy, and if this fails, proceed to opioid rotation or carefully titrated mu-opioid antagonists rather than ondansetron, which is ineffective for this indication. 1, 2, 3

Initial Assessment and First-Line Treatment

Before initiating treatment, assess for other causes of pruritus including other medications and underlying dermatological or systemic conditions, as pruritus is more likely to occur early in opioid treatment. 1, 2

Begin with antihistamines despite limited mechanistic rationale:

• Diphenhydramine 25-50 mg IV or PO every 6 hours (sedating option) 1, 3
• Promethazine 12.5-25 mg PO every 6 hours (sedating option) 1
• Cetirizine as a non-sedating alternative 1

Important caveat: Sedating antihistamines may compound opioid-induced sedation, requiring close monitoring. 1

Second-Line: Opioid Rotation

If antihistamines fail, consider rotating to a different opioid (e.g., switching from morphine to oxycodone or fentanyl), as different opioids have varying propensities to cause pruritus. 1, 4 This preserves analgesia while potentially eliminating the pruritus entirely.

Third-Line: Opioid Antagonists (With Careful Titration)

When both antihistamines and opioid rotation fail, use mu-opioid receptor antagonists or mixed agonist-antagonists with meticulous dose titration to avoid reversing analgesia:

• Nalbuphine (mixed agonist-antagonist): 0.5-1 mg IV every 6 hours as needed—this maintains some analgesia while treating pruritus 1, 3
• Naloxone (continuous infusion): Start at 0.25 mcg/kg/h and titrate upward carefully 1, 3
• Naltrexone: First-choice when opioid cessation is impossible 1, 3
• Methylnaltrexone: Peripheral antagonist with reduced CNS penetration, may better preserve analgesia 1, 2, 3

Critical pitfall: Full doses of opioid antagonists will reverse analgesia and may precipitate withdrawal in opioid-dependent patients—careful dose titration is essential. 2, 3

Alternative Pharmacologic Options

If the above approaches fail:

• Mirtazapine or gabapentin as alternative antipruritic agents 1, 3
• Droperidol for refractory cases 1

What NOT to Use

Do not use ondansetron for opioid-induced pruritus. The British Association of Dermatologists explicitly states that ondansetron and other 5-HT3 receptor antagonists do not reduce the incidence or time to onset of opioid-induced pruritus compared to placebo, despite their efficacy for opioid-induced nausea. 2, 3 While some older evidence suggested benefit, more recent studies have refuted this. 2

Preventive Strategies

For patients at high risk (e.g., perioperative settings):

• Mirtazapine 30 mg daily 3
• Gabapentin 1200 mg daily in divided doses 3

Epidemiology Context

The incidence varies dramatically by route: 2-10% with oral opioids, 10-50% with IV opioids, and 20-100% with neuraxial (epidural/intrathecal) opioids. 2, 3 This high incidence with neuraxial administration makes prophylaxis particularly important in these settings.